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Summary An 87-year-old man was admitted to hospital because of fever, productive cough,
dyspnea and altered consciousness. His medical history was significant for chronic obstructive
pulmonary disease. He owned several pets. Physical examination and a chest radiograph revealed
right upper lobe pneumonia. Blood cultures taken on admission yielded Pasteurella multocida and
antimicrobial susceptibility testing showed susceptibility to b-lactams. The fever subsided four
days after treatment with intravenous ceftriaxone and the patient was discharged in a very good
clinical condition after two weeks of treatment. Although no history of bites or scratches was
documented, it is likely that our patient was exposed to the secretions of his many pets through
inhalation of contaminated aerosols. This resulted in tracheobronchial tree colonization by P.
multocida, which later developed into pneumonia. Close animal contact should be avoided by
frail, elderly patients with chronic pulmonary diseases, as it is a risk factor for pneumonia due to
Pasteurella spp.
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Pasteurella multocida is a Gram-negative coccobacillus and
is known to be a zoonotic agent of human disease.1—4 The
organism can be isolated from oropharyngeal secretions of
domestic animals, particularly cats, dogs and pigs, as well as
various wild animals.1,3—6 Approximately half of P. multocida
infections are due to animal bites or animal exposure, usually* Corresponding author. Department of Internal Medicine, Univer-
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doi:10.1016/j.ijid.2008.06.023cats.1,3,4,7,8 Cases unrelated to animals have also been
reported.1,2,4,9 Local wound infections can be complicated
by abscess formation, osteomyelitis or septic arthritis.1,10
P. multocida can cause a variety of upper and lower
respiratory tract infections. Most patients have underlying
lung disease.1—4,10,11 However, P. multocida is often a com-
mensal organism of the respiratory tract, especially in
patients with underlying pulmonary disease, hence compli-
cating the assessment of a positive sputum culture. A variety
of other serious invasive infections, such as meningitis,
bacteremia, endocarditis and peritonitis, have also been
reported, but are rare.1,10
P. multocida bacteremia can occur by spread from a
localized bite wound or from another localized infection,Published by Elsevier Ltd. All rights reserved.
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minantly in patients with preexisting liver disease or in
immunosuppressed patients.1—3,10,12,13
We report a rare case of bacteremic P. multocida pneu-
monia in an 87-year-old man with chronic obstructive pul-
monary disease (COPD), possibly transmitted by close
contact with pets.
Case report
An 87-year-old man was admitted to hospital because of
fever, cough, dyspnea and altered consciousness. He had
been well until two days earlier, when he developed a high
fever up to 39 8C, chills and an increasing purulent productive
cough. His medical history was significant for COPD, hyper-
tension, atrial fibrillation, myocardial infarction and conges-
tive heart failure. He owned six cats and a dog. No bites or
scratches were mentioned.
On admission, his temperature was 38.4 8C, pulse rate 117
beats/min, blood pressure 117/72 mmHg and respiratory
rate 30/min. The patient had hypoxia with partial oxygen
pressure 45 mmHg and oxygen saturation 82% on room air. On
examination, he was tachypneic and mildly dehydrated.
Chest auscultation revealed diffuse crackles, with egobron-
cophony at the apex of the right lung. No skin lesions or
enlarged lymph nodes were found. Chest X-ray showed right
upper lobe consolidation (Figure 1).
His initial leukocyte count was 10.7  109 cells/l, with an
absolute neutrophil count of 9523/ml. Once pneumonia was
diagnosed, specimens for blood and sputum cultures were
obtained and the patient was started on empiric antibiotic
therapy with ceftriaxone (2 g/day) and azithromycin
(500 mg/day) intravenously. By the second day of incubation,
growth was detected in both blood cultures taken. Positive
samples were subcultured onto Columbia blood agar plates
(BioMe´rieux, Marcy l’ Etoile, France), yielding smooth, gray,
non-hemolytic colonies. Microscopy revealed Gram-negative
coccobacilli. The microorganism was identified as P. multo-
cida using standard microbiological methods and the API
20NE system (BioMe´rieux).14 Antimicrobial susceptibility
testing was performed by the disk diffusion method followingFigure 1 Chest radiograph at the time of hospital admission.
This postero-anterior view shows lobar pneumonia in the right
upper lobe.the recommendations of the Clinical and Laboratory Stan-
dards Institute (CLSI).15 The isolate was susceptible to b-
lactams, quinolones, tetracycline, chloramphenicol and tri-
methoprim-sulfamethoxazole, resistant to macrolides and
amikacin, and moderately resistant to gentamicin and tobra-
mycin. After the in vitro sensitivity became available, the
patient continued treatment with intravenous ceftriaxone
alone for a total of 14 days. The fever subsided four days after
treatment initiation and the patient was then discharged
home in a very good clinical condition.
Discussion
Pasteurellae are coccoid to small Gram-negative, faculta-
tively anaerobic, non-motile and non-spore-forming rods,
measuring 1—2 mm in length.1 P. multocida exists as ‘normal
flora’ in the oropharyngeal cavity of cats, dogs, pigs and
other domestic and wild animals.1,3,6
In humans, P. multocida causes a wide spectrum of dis-
eases. Skin and soft-tissue infections are the most common,
and result from animal scratches or bites.1,3,4,7,8 Its isolation
and identification are not difficult, as it grows well on blood
and chocolate agar. However, it is easily overgrown by other
flora in sputum and might be easily missed, as it resembles
Haemophilus influenzae, Francisella tularensis and Yersinia
pestis. Five species or subspecies cause the majority of
pasteurellosis in humans: P. multocida, P. septica, P. canis,
P. stomatis and P. dagmatis.1,16
Pasteurella is transmitted to humans via direct contact
with animal secretions after biting, scratching, licking or
kissing, although a history of such exposure cannot always
be elicited, as in the present case.1,3,4,7—9 However, it is
almost certain that our elderly patient was exposed to the
secretions of his many pets through inhalation of contami-
nated aerosols and this probably resulted in tracheobronchial
tree colonization and, later, pneumonia, as previously
described.1,13
Local wound infections following animal bites or
scratches are the most common P. multocida infections.
Typically, they present with rapid onset of pain, erythema,
swelling and fever.1,10 The respiratory tract is the second
most common site of infection.1—4,6,8,10,11 In a group of 108
patients with Pasteurella pleuropulmonary infections, 49
had pneumonia, 37 tracheobronchitis, 25 empyema and 3
had lung abscesses.11 The incidence of P. multocida infec-
tions is low in our institution. Thirteen cases were diagnosed
during a 12-year period, with respiratory tract infections
being the most frequent.17 The majority of P. multocida
pneumonia cases occur in elderly patients with underlying
chronic pulmonary disease, as in this patient.1,2,4,5,10 Hub-
bert and Rosen reviewed 136 P. multocida infections unre-
lated to animal bites. Among them, 80 involved the
respiratory tract and all patients had chronic pulmonary
disease.9 However, the incidence of P. multocida respiratory
tract infections in everyday clinical practice remains
unknown, as the chance of determining the causative patho-
gen of community-acquired pneumonia is less than 6% in
outpatients and 25% in inpatients, and is even lower for
upper respiratory tract infections.18 On the other hand, as P.
multocidamight be a commensal organism of the respiratory
tract in patients with underlying lung disease, its isolation
from the respiratory tract is difficult to interpret.1 The
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is thought to be high, although large sample groups are
lacking.1—6,11 In one group of 49 patients with pneumonia,
bacteremia was found in 55% of the patients.11
The treatment of choice for P. multocida infections is
penicillin.1,19 However, penicillin-resistant P. multocida
strains in human infections have been described.20,21 In these
cases, second- and third-generation cephalosporins, fluoro-
quinolones and tetracyclines are recommended for treat-
ment.1,19 We did not use penicillin in our patient, despite the
in vitro sensitivity, because he had already responded nicely
to the initially chosen intravenous ceftriaxone, whereas
azithromycin was discontinued because the isolated organ-
ism was resistant to macrolides.
A high mortality rate approaching 30% has been reported
for patients with P. multocida infections and bacteremia,
pneumonia, meningitis, arthritis or peritonitis.1,11,13 For
these patients, a prolonged antibiotic course is typically
required.
In conclusion, P. multocida is an important pathogen in
humans, where it can cause serious life-threatening infec-
tions, especially in those with underlying chronic lung dis-
ease. Avoidance of animal contact is a simple measure for
preventing pasteurellosis in this frail population at increased
risk of death. Finally, obtaining a detailed patient history
about animal exposure is of paramount importance for the
diagnosis of infections due to Pasteurella spp.
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